Vitrolife's Chief Financial Officer (CFO) Mikael Engblom has today resigned from his position. A process to recruit a replacement will be initiated and Mikael Engblom will continue in his current role until a new CFO takes office. Mikael Engblom has been CFO since 2011 and before that worked as a controller at the company.
'During his time as CFO, Mikael has played a key role in transforming the company from a small niche company to a very profitable market-leading player in reproductive health with an international ownership base through internal efficiency work, strategy plans and acquisitions,' says Thomas Axelsson, CEO. 'I would like to thank Mikael for good cooperation and his valuable contribution to the company's exceptional development over the past ten years and wish him best of luck for the future,' says Thomas Axelsson, CEO.
'Vitrolife is facing a new exciting growth journey, but after ten developing years as CFO at Vitrolife, I have decided that it is time for a new challenge,' says Mikael Engblom.
Gothenburg, September 2, 2021
VITROLIFE AB (publ)
Thomas Axelsson, CEO
Attachments
Original document
Permalink
Disclaimer
Vitrolife AB published this content on 02 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 September 2021 13:11:05 UTC.
Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Companyâs product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.
VITROLIFE AB 
